Related Experiment Video
Updated: Jul 21, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Teneligliptin Co-Infusion Alleviates Morphine Tolerance by Inhibition of Spinal Microglial Cell Activation in
Yaswanth Kuthati1, Vaikar Navakanth Rao2, Wei-Hsiu Huang1
1Department of Anesthesiology, Cathy General Hospital, Taipei 106, Taiwan.
Abstract:
Morphine (MOR) is a commonly prescribed drug for the treatment of moderate to severe diabetic neuropathic pain (DNP). However, long-term MOR treatment is limited by morphine analgesic tolerance (MAT). The activation of microglial cells and the release of glia-derived proinflammatory cytokines are known to play an important role in the development of MAT. In this study, we aimed to investigate the effects of the dipeptidyl peptidase-4 inhibitor (DPP-4i) teneligliptin (TEN) on MOR-induced microglial cell activation and MAT in DNP rats. DNP was induced in four groups of male Wistar rats through a single intraperitoneal injection of streptozotocin (STZ) (50 mg/kg, freshly dissolved in 5 mmol/L citrate buffer, pH 4.5). Sham rats were administered with the vehicle. Seven days after STZ injection, all rats were implanted with an intrathecal (i.t) catheter connected to a mini-osmotic pump, divided into five groups, and infused with the following combinations: sham + saline (1 µL/h, i.t), DNP + saline (1 µL/h, i.t), DNP + MOR (15 µg/h, i.t), DNP + TEN (2 µg/h, i.t), and DNP + MOR (15 µg/h, i.t) + TEN (2 µg/h, i.t) for 7 days at a rate of 1 μL/h. The MAT was confirmed through the measurement of mechanical paw withdrawal threshold and tail-flick tests. The mRNA expression of neuroprotective proteins nuclear factor erythroid 2-related factor (Nrf2) and heme oxygenase-1 (HO-1) in the dorsal horn was evaluated by quantitative PCR (qPCR). Microglial cell activation and mononucleate cell infiltration in the spinal cord dorsal horn were assessed by immunofluorescence assay (IFA) and Western blotting (WB). The results showed that co-infusion of TEN with MOR significantly attenuated MAT in DNP rats through the restoration of neuroprotective proteins Nrf2 and HO-1 and suppression of microglial cell activation in the dorsal horn. Though TEN at a dose of 2 μg has mild antinociceptive effects, it is highly effective in limiting MAT.
Insights
Teneligliptin (TEN) can limit morphine analgesic tolerance (MAT) in diabetic neuropathic pain (DNP) rats. This dipeptidyl peptidase-4 inhibitor (DPP-4i) suppresses microglial activation and restores neuroprotective proteins, offering a potential strategy to improve long-term pain management.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Morphine (MOR) effectively treats moderate to severe diabetic neuropathic pain (DNP) but long-term use is limited by morphine analgesic tolerance (MAT).
- Microglial cell activation and pro-inflammatory cytokine release are key contributors to MAT development.
- Dipeptidyl peptidase-4 inhibitors (DPP-4i) like teneligliptin (TEN) are explored for their potential in modulating pain pathways.
Purpose of the Study:
- To investigate the effects of teneligliptin (TEN) on morphine-induced microglial activation and morphine analgesic tolerance (MAT) in a rat model of diabetic neuropathic pain (DNP).
Main Methods:
- Diabetic neuropathic pain (DNP) was induced in Wistar rats using streptozotocin (STZ).
- Rats received intrathecal (i.t.) administration of saline, MOR, TEN, or MOR + TEN for 7 days.
- Morphine analgesic tolerance (MAT) was assessed via mechanical paw withdrawal and tail-flick tests.
- Neuroprotective proteins (Nrf2, HO-1) and microglial activation in the spinal cord dorsal horn were evaluated using qPCR, immunofluorescence assay (IFA), and Western blotting (WB).
Main Results:
- Co-infusion of TEN with MOR significantly attenuated MAT in DNP rats.
- TEN treatment restored the expression of neuroprotective proteins nuclear factor erythroid 2-related factor (Nrf2) and heme oxygenase-1 (HO-1) in the dorsal horn.
- TEN suppressed microglial cell activation and mononucleate cell infiltration in the spinal cord dorsal horn.
- TEN (2 μg) demonstrated mild antinociceptive effects but was highly effective in limiting MAT.
Conclusions:
- Teneligliptin (TEN) effectively attenuates morphine analgesic tolerance (MAT) in diabetic neuropathic pain (DNP) rats.
- The mechanism involves the restoration of Nrf2/HO-1 neuroprotective pathways and suppression of spinal microglial activation.
- TEN represents a promising therapeutic strategy to enhance the long-term efficacy of morphine for DNP management.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Analgesia and Pain Management
Oral Hypoglycemic Agents: Biguanides and Glitazones
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Oral Hypoglycemic Agents: Glinides

